Pharmacogenomics Flashcards

1
Q

Define pharmacogenetics and describe how it

can be used to enhance patient care.

A

The study of genetic factors that underlie the variation in drug responses.

Understand how genetic differences influence the DRUG RESPONSE

  • Identify patients that will respond to drug treatment
  • Maximize drug efficacy
  • Optimize drug dosing
  • Minimize drug toxicity
  • Aid in new drug developmen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the main factors that can affect the genetic variability of the drug response.

A

Pharmacokinetics (what body does to drug)

  • drug metabolizing enzymes
  • drug transporters

(Polymorphisms in genes result in diff in how effective drug is, and how the enzymes/transporters work)

Pharmacodynamics (what drug does to body)

  • drug therapeutic targets
  • drug toxic targets

Leads to dosing, efficacy and adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common factor responsible for pharmacogentic differences in drug response?

A

Differences between individuals in the enzymes of drug metabolism

Many of the enzymes involved in drug metabolism are polymorphic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe how genetic polymorphisms in drug metabolizing enzymes can affect the metabolism of drugs and the effects that
this has on serum drug concentration, drug
efficacy and the risk of toxicity.

A
  • existence of different alleles of a single gene within the population
  • different alleles exhibit different degrees of metabolic activity
  • The CYP450 family of drug metabolizing enzymes are highly polymorphic especially CYP2D6, 2C9 and 2C19
  • increased/decreased/unchanged/absent/null enzyme activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe how polymorphisms in drug transporter proteins can contribute towards the variability in drug responses.

A

Drug transporters mediate the influx or efflux of drugs in to or out of cells

Play an important role in determining plasma and tissue levels of a drug

Genetic polymorphisms in drug transporters can dramatically alter drug disposition and drug responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe how polymorphisms in drug target proteins can contribute towards the
variability in drug responses.

A

Genetic variations in drug targets or downstream signaling proteins can also influence the drug response

  • Zileuton decreases airway inflammation in asthma by inhibiting 5-lipoxygenase (ALOX5)
    • Variations in the promoter of the ALOX5 gene influence the response to Zileuton
  • Most common allele contains 5 copies of binding site for the SP1 transcription factor
  • Common variants contain 4 or 3 copies (express less ALOX5 than common allele)
  • Presence of the common allele or variant does not influence disease severity
  • But does influence the response to Zileuton

so those with two variant alleles will not respond to Zileuton bc they are producing significantly less 5 lipoxygenase (the enzyme on which Zileuton acts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe how polymorphisms in CYP2C9 and VKORC1 each contribute towards the variability in the response to warfarin.

A

Pharmacokinetics-
2C9*2 and 3 - reduced function variants
2C9
15 and *25 – null variants

patients w *2 or *3

  • decreased metabolic inactivation of S-warfarin
  • increased concentration of active warfarin with standard dose
  • prone to experiencing bleeding events
  • patients require lower warfarin dosing

Pharmacodynamics

  • VKORC1 is the direct target of warfarin
  • Common polymorphism found in the VKORC1 promoter region: -1639G to A
  • G is associated with higher VKORC1 expression and a higher warfarin dose
  • A is associated with lower VKORC1 expression and a lower warfarin dose needed
  • 37% whites, 14% Africans & 90% Asians carry the A-allele

-Rare mutations in the VKORC1 coding region are associated with warfarin resistance (reduced affinity) that require v. high doses of warfarin to achieve anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Discuss the different mechanisms by which genetic polymorphisms can contribute towards drug-induced adverse effects.

A

Can result from interaction of drug with its true target or a different target protein

Idiosyncratic drug reactions/hypersensitivity reactions- unrelated to PK or PD effects
- result from unanticipated interaction between drug and unique patient physiology

Pharmacokinetic based adverse reactions:

  • polymorphisms in drug metabolizing enzymes causing elevated drug levels
  • polymorphisms in drug transporters causing elevated drug levels

Pharmacodynamic-based adverse reactions
-polymorphisms in drug targets affect drug responsiveness (e.g. warfarin and VKORC1)

Drug-induced hepatotoxicity

Drug-induced hypersensitivity reactions (Allergic-like reactions, often life threatening)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List some of the current barriers to the full implementation of pharmacogenetics into
clinical practice.

A

Physician education and understanding of pharmacogenetics

Absence of data demonstrating clinical utility

Lack of evidence for added value to existing prescribing method

Availability of alternative medications where genetic variability is not an issue

Cost effectiveness

Timeliness of turnaround for genetic testing

Lack of reimbursement for tests/Insurance coverage

Lack of clear clinical guidelines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define targeted therapy and explain how pharmacogenetic data
is used in the therapeutic
decision making process.

A

Therapy that is targeted towards a molecular target based upon unique mutations or genetics

Typically, used in the treatment of specific cancers

Treatment is based upon specific somatic mutations in key oncogenic drivers unique to the patient’s cancer
- Drug is only given to those patients with the specific mutation

Trastuzumab (Herceptin), an anti-Her2/ErbB2 monoclonal antibody used to treat breast cancer in patients whose tumor overexpresses the Her2/ErbB2 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which of the following, when variant, is least likely to cause significant difference in enzymatic activity between individuals?

CYP2C9
CYP3A4
CYP2D6
CYP2C19

A

ALL polymorphic; however, CYP3A4 alleles are v rare, little difference in enzymatic activity between individuals, redundancy with CYP3A5, polymorphisms are unlikely to be clinically significant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What accounts for differences in drug responses between ethnic groups?

A

CYP450 alleles are differentially distributed amongst racial and ethnic groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A patient presents with severe broken leg and is in extreme pain; you prescribe x amount of codeine but thirty minutes later is still writhing in pain; you double check the dose and that it was administered but there were no errors. What might explain this?

A

drug isn’t working
-codeine is a Prodrug

-patient has variant form of 2D6 - could lead to poor metabolize and consequently decreased efficacy and lack of sedative effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What ethnic population is most likely to carry a VKORC1 variant allele? What are the implications of this?

A

90 percent of Asians carry A-allele

A is associated with lower VKORC1 expression and a lower warfarin dose needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What will decreased activity in an influx pump result in?

Discuss efficacy.
What if its expressed in liver?
Toxicity?

A
  • Reduced cellular uptake
  • Decreased efficacy
  • If expressed in liver can affect drug metabolism and elimination
  • Potential for increased “off target” toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What will decreased activity in efflux pump result in?

Discuss cell excretion, efficacy, toxicity, drug excretion, BBB

A
  • Reduced cell excretion
  • Potentially increased efficacy
  • Potentially increased toxicity
  • Potential for decreased drug excretion
  • Potential for compromising blood brain barrier
17
Q

A Han Chinese man with a HLAB*1502 allele presents with a diffuse red rash all over his body; you quickly check his medications and realize the mistake that has been made. Explain.

A

e.g. Carbamazepine-induced Steven Johnson Syndrome

FDA recommends Pharmacogenetic testing to be used to screen Asian patients requiring carbamazepine in order to avoid SJS

  • linked to HLA-B*1502 in Han Chinese